The effects of different doses of dexmedetomidine on the requirements for propofol for loss of consciousness in patients monitored via the bispectral index: a double-blind, placebo-controlled trial

BACKGROUND: The α(2)-adrenergic agonist dexmedetomidine (DEX) is a sedative and can be used as an adjunct to hypnotics. The study sought to evaluate the effects of different doses of DEX on the requirements for propofol for loss of consciousness (LOC) in patients monitored via the bispectral index (...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yang, Yang, Fan, Zhang, Yonghai, Zheng, Junwei, Wang, Jie, Li, Bin, Ma, Tao, Cui, Xiang, Lu, Kaimei, Ma, Hanxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183661/
https://www.ncbi.nlm.nih.gov/pubmed/32334510
http://dx.doi.org/10.1186/s12871-020-01013-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183661/
https://www.ncbi.nlm.nih.gov/pubmed/32334510
http://dx.doi.org/10.1186/s12871-020-01013-x

Ejemplares similares